Rare Neoplasm — Sources & provenance

Rare Neoplasm — Sources & provenance · CancerIndex

Provenance

Sources contributing to this entity

Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.

Source	License	Contributions	Ingest runs	Last retrieved
cBioPortal for Cancer Genomics (public studies) cbioportal	approved	Genomic Cohorts	—	Sep 8, 2026, 01:24 PM UTC
CIViC — Clinical Interpretation of Variants in Cancer civic	approved	Evidence	ING-CIVIC-20260930-000001	Sep 30, 2026, 02:02 AM UTC
EMA — European public assessment reports (centrally authorised medicines) ema	approved	Approvals	—	Sep 30, 2026, 05:00 AM UTC
NCI Thesaurus (NCIt) ncit-evs	approved	Aliases, Codes, Description, Hierarchy, Source Records	ING-NCITEVS-20260908-000001	Sep 8, 2026, 09:44 AM UTC
openFDA — Drugs@FDA applications and drug labels (SPL) openfda	approved	Approvals	—	Sep 28, 2026, 04:03 AM UTC

Identifiers

Every upstream identifier is kept with its match type; nothing is buried in JSON.

System	Code	Match type	Source
NCIt	C7201	EXACT_IDENTIFIER	ncit-evs

Names

Alias	Type	Terminology	Language
Rare Neoplasm	preferred	NCIt	en
Rare Tumor	synonym	NCIt	en

Change history

Creation, updates, merges and ranking changes recorded for this entity.

CreatedCreated from NCIt C7201 (Rare Neoplasm)Sep 8, 2026
ING-NCITEVS-20260908-000001